RxDoctor Payments Data

Catherine Cunningham, MD

Psychiatry · Lakewood, NJNPI 1982009486

Payments from drug & device makers

$2,106in general payments, 2019–2025

Across 140 payments — averaging $15.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$426
  • AbbVie$301
  • Otsuka America Pharmaceutical, Inc.$203
  • Teva Pharmaceuticals USA, Inc.$172
  • Corium, LLC$142
  • Vanda Pharmaceuticals Inc.$131
  • plus $730 from 16 others

What the payments were for

  • Food & beverage$2,05698%
  • Education$502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,106 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$28,988
Medicare patients
133
Services billed
235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$48,129
Abilify MaintenaAripiprazole13$36,126
AristadaAripiprazole Lauroxil11$34,161
VivitrolNaltrexone Microspheres15$27,347
NuedextaDextromethorphan Hbr/Quinidine11$20,398
RexultiBrexpiprazole15$19,809
Paliperidone ErPaliperidone24$9,028
Aripiprazole68$5,770
Clozapine30$2,706
Fluoxetine Hcl36$1,594
Divalproex Sodium ErDivalproex Sodium30$1,515
Bupropion XlBupropion Hcl45$1,267
Olanzapine27$1,081
Venlafaxine Hcl ErVenlafaxine Hcl49$1,063
Quetiapine Fumarate48$926

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada, Vivitrol$73$61,50826 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$203$55,93528 claims
Johnson & JohnsonInvega Sustenna$71$48,12915 claims
Avanir Pharmaceuticals, Inc.Nuedexta$43$20,39811 claims
Lilly USA, LLCOlanzapine$22$1,08127 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Lakewood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →